 3i Infotech Limited allots 3,77,08,165 equity shares on rights basis, Issue oversubscribed 1.45 times
3i Infotech Limited allots 3,77,08,165 equity shares on rights basis, Issue oversubscribed 1.45 times Reliance Power Ltd appoints retired IAS Officer Ms. Zohra Chatterji as Independent Director
Reliance Power Ltd appoints retired IAS Officer Ms. Zohra Chatterji as Independent Director Airfloa Rail Technology Ltd receives order worth Rs. 23.91 crores
Airfloa Rail Technology Ltd receives order worth Rs. 23.91 crores Macfos Ltd consolidated Q2FY26 net profit up QoQ at Rs. 5.10 crore
Macfos Ltd consolidated Q2FY26 net profit up QoQ at Rs. 5.10 crore Jasch Gauging Technologies Ltd Q2 FY2025-26 net profit at Rs. 5.13 crore
Jasch Gauging Technologies Ltd Q2 FY2025-26 net profit at Rs. 5.13 crore 
              Dermozone, a global wound healing and Herbal Skincare Products Company, announced that it has set up office in Chennai, it's second in India after Bengaluru. The Chennai office, located at Annasalai ,would be an extension of the company's existing Bengaluru office and also be the operations hub for Dermozone in India.
Dermozone, with headquarters in Jakarta, Indonesia had in the last quarter of 2015 announced its entry into the Indian market, by setting up an office in Bengaluru in the name of Indo- Dermozone Herbal Pvt. Ltd. Dermozone also has operations in UK, USA, Japan, Russia, Seoul, China, Taiwan, Hong Kong, South Africa, Brazil, Argentina, Mexico, Chile, Australia and Dubai (Middle East).
"We are extremely pleased to announce the opening of our Chennai office and would be very soon unveiling in India our renowned herbal Skincare products under our two brands -'MedCare' and 'BodyCare'." said Mr. K.S. Dharshan, Chairman & CEO of Dermozone." 'MedCare' brand comprises of four products- WoundCare (wound and burn), VaginyCare (feminine usage), BabyCare (allergies, rashes etc) and MedCare Soap. 'BodyCare' caters to the cosmetics and beauty care market with a range of seventeen products."
"Dermozone had recently announced that it had developed 'dalethyne ', a revolutionary chemical molecule compound, proven as an antimicrobial agent against most of the bacteria, fungi and yeasts. Dermozone's best kept secret, 'dalethyne 'will be the key ingredient in the company's MedCare and BodyCare range of herbal products soon to be launched in India." said Mr. Manjunatha K.G, Chief Operation Officer of Indo- Dermozone Herbal Pvt. Ltd. "Currently, Dermozone's MedCare product 'WoundCare' is under clinical trial at Apollo Hospitals, Chennai and expected to be completed by the second quarter of 2016."